Immunotherapy Drugs Market - Global Industry Analysis

Immunotherapy Drugs Market

Global Immunotherapy Drugs Market By Size, Share, and Forecast 2028

Category: Pharmaceutical Report Format : PDF Pages: 110 Report Code: ZMR-1811 Published Date: Jan-2019 Status : Published

The report covers a forecast and an analysis of the immunotherapy drugs market on a global and regional level. The study provides historical data from 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints for the immunotherapy drugs market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the immunotherapy drugs market on a global and regional level.

Table Of Content

Methodology

Free Analysis

Immunotherapy uses the body’s immune system to fight against various disorders, such as cancer, infectious diseases, autoimmune, and inflammatory diseases. Immunotherapy includes the use of monoclonal antibodies and various checkpoint inhibitors that disrupt signals that protect cancer cells from immune attack, preventive, and therapeutic vaccines, and cytokines, such as interferon, interleukin etc. Immunotherapy is widely adopted in cancer treatments, owing to lesser side-effects as compared to chemotherapy.

The prevalence of cancer is growing worldwide and it was the second leading cause of death in the year 2018. As per the World Health Organization (WHO) 2018 estimates, there were about 18.1 million new cancer cases and 9.6 million global deaths caused by cancer. The incidence of lifestyle-related disorders is rapidly increasing, which, in turn, is likely to drive the demand for immunotherapy drugs market in the future. The increasing preference for targeted therapy with lesser side-effects over traditional therapy is anticipated to further fuel the immunotherapy drugs market in the future. Additionally, the emergence of new biosimilars, rapid drug approvals, and increased demand for monoclonal antibodies (mAbs) are projected to boost the immunotherapy drugs market growth over the estimated timeframe. Other factors likely to contribute toward the immunotherapy drugs market growth are rising geriatric population base, increasing health awareness, increased disposable income and healthcare spending, and favorable reimbursement policies. However, the high cost of immunotherapy drugs might limit the immunotherapy drugs market in the future. Emerging markets and immunotherapy as a substitute for chemotherapy is likely to create new growth opportunities for the immunotherapy drugs market on a global scale.

Global Immunotherapy Drugs Market

The global immunotherapy drugs market is segmented based on drug type, therapeutic application, and end-user. By drug type, the market is segmented into adult vaccines, monoclonal antibodies, checkpoint inhibitors, interleukins, interferon alpha and beta, and others. Preventive vaccines and therapeutic vaccines comprise the adult vaccines segment. Monoclonal antibodies drug type segment held the largest share of the global immunotherapy drug market in 2017, owing to the preference for targeted therapy with lesser side effects. By therapeutic application, this global market is segmented into autoimmune and inflammatory diseases, cancer, infectious diseases, and others. Cancer segment is further divided into the solid tumor and malignant. The cancer therapeutic application segment held the largest share of global immunotherapy drugs market, owing to increasing cancer prevalence globally. Hospitals, clinics, and others form the end-user segment of the global immunotherapy drugs market. Hospitals dominated the immunotherapy drugs market in 2017 and are expected to lead in the future as well.

By region, North America dominated the global immunotherapy drugs market in 2018 with a revenue share of about 40%. This can be attributed to the presence of key players, increasing preference for targeted immunotherapy over other therapies, favorable reimbursement policies, and developed healthcare infrastructure. North America is likely to maintain its top position over the forecast time period as well. Europe is the second largest regional market for immunotherapy drugs in 2018. The Asia Pacific region is estimated to register the highest CAGR over the forecast time period, owing to increasing health awareness, growing healthcare spending, and rising disposable income. The Middle Eastern and African region is likely to experience noticeable growth in the years ahead. Latin America is projected to exhibit a moderate rate of growth for immunotherapy drugs market over the forecast time period.

Some key players of the immunotherapy drugs market include F. Hoffmann-La Roche AG, Amgen, Inc., Novartis International AG, AbbVie, Inc., Merck & Co., Inc., GlaxoSmithKline, Eli Lilly and Company, Bristol-Myers Squibb, AstraZeneca plc, and Johnson & Johnson, among others.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed